Literature DB >> 24227848

Risk assessment of H2N2 influenza viruses from the avian reservoir.

Jeremy C Jones1, Tatiana Baranovich, Bindumadhav M Marathe, Angela F Danner, Jon P Seiler, John Franks, Elena A Govorkova, Scott Krauss, Robert G Webster.   

Abstract

H2N2 influenza A viruses were the cause of the 1957-1958 pandemic. Historical evidence demonstrates they arose from avian virus ancestors, and while the H2N2 subtype has disappeared from humans, it persists in wild and domestic birds. Reemergence of H2N2 in humans is a significant threat due to the absence of humoral immunity in individuals under the age of 50. Thus, examination of these viruses, particularly those from the avian reservoir, must be addressed through surveillance, characterization, and antiviral testing. The data presented here are a risk assessment of 22 avian H2N2 viruses isolated from wild and domestic birds over 6 decades. Our data show that they have a low rate of genetic and antigenic evolution and remained similar to isolates circulating near the time of the pandemic. Most isolates replicated in mice and human bronchial epithelial cells, but replication in swine tissues was low or absent. Multiple isolates replicated in ferrets, and 3 viruses were transmitted to direct-contact cage mates. Markers of mammalian adaptation in hemagglutinin (HA) and PB2 proteins were absent from all isolates, and they retained a preference for avian-like α2,3-linked sialic acid receptors. Most isolates remained antigenically similar to pandemic A/Singapore/1/57 (H2N2) virus, suggesting they could be controlled by the pandemic vaccine candidate. All viruses were susceptible to neuraminidase inhibitors and adamantanes. Nonetheless, the sustained pathogenicity of avian H2N2 viruses in multiple mammalian models elevates their risk potential for human infections and stresses the need for continual surveillance as a component of prepandemic planning.

Entities:  

Mesh:

Year:  2013        PMID: 24227848      PMCID: PMC3911670          DOI: 10.1128/JVI.02526-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

Authors:  Chung-Lam Cheung; Jane M Rayner; Gavin J D Smith; Pui Wang; T S P Naipospos; Jinxia Zhang; Kwok-Yung Yuen; Robert G Webster; J S Malik Peiris; Yi Guan; Honglin Chen
Journal:  J Infect Dis       Date:  2006-05-09       Impact factor: 5.226

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Vaccinate for the next H2N2 pandemic now.

Authors:  Gary J Nabel; Chih-Jen Wei; Julie E Ledgerwood
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

4.  Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.

Authors:  Adrianus C M Boon; Jennifer deBeauchamp; Scott Krauss; Adam Rubrum; Ashley D Webb; Robert G Webster; Janet McElhaney; Richard J Webby
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

6.  Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Geert van Amerongen; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan; Thijs Kuiken
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

Review 7.  Pandemic (H1N1) 2009 virus revisited: an evolutionary retrospective.

Authors:  Mary C Christman; Ambreen Kedwaii; Jianpeng Xu; Ruben O Donis; Guoqing Lu
Journal:  Infect Genet Evol       Date:  2011-03-05       Impact factor: 3.342

8.  Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.

Authors:  Taronna R Maines; Li-Mei Chen; Neal Van Hoeven; Terrence M Tumpey; Ola Blixt; Jessica A Belser; Kortney M Gustin; Melissa B Pearce; Claudia Pappas; James Stevens; Nancy J Cox; James C Paulson; Rahul Raman; Ram Sasisekharan; Jacqueline M Katz; Ruben O Donis
Journal:  Virology       Date:  2011-03-23       Impact factor: 3.616

9.  Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.

Authors:  Jack T Nguyen; Donald F Smee; Dale L Barnard; Justin G Julander; Matthew Gross; Menno D de Jong; Gregory T Went
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

10.  The potential of avian H1N1 influenza A viruses to replicate and cause disease in mammalian models.

Authors:  Zeynep A Koçer; Scott Krauss; David E Stallknecht; Jerold E Rehg; Robert G Webster
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more
  33 in total

1.  Evaluation of multivalent H2 influenza pandemic vaccines in mice.

Authors:  Brian J Lenny; Stephanie Sonnberg; Angela F Danner; Kimberly Friedman; Richard J Webby; Robert G Webster; Jeremy C Jones
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 3.641

2.  Respiratory transmission of an avian H3N8 influenza virus isolated from a harbour seal.

Authors:  Erik A Karlsson; Hon S Ip; Jeffrey S Hall; Sun Woo Yoon; Jordan Johnson; Melinda A Beck; Richard J Webby; Stacey Schultz-Cherry
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

3.  Potential for Low-Pathogenic Avian H7 Influenza A Viruses To Replicate and Cause Disease in a Mammalian Model.

Authors:  Mark Zanin; Zeynep A Koçer; Rebecca L Poulson; Jon D Gabbard; Elizabeth W Howerth; Cheryl A Jones; Kimberly Friedman; Jon Seiler; Angela Danner; Lisa Kercher; Ryan McBride; James C Paulson; David E Wentworth; Scott Krauss; Stephen M Tompkins; David E Stallknecht; Robert G Webster
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice.

Authors:  Troy C Sutton; Elaine W Lamirande; Kevin W Bock; Ian N Moore; Wouter Koudstaal; Muniza Rehman; Gerrit Jan Weverling; Jaap Goudsmit; Kanta Subbarao
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

5.  Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.

Authors:  Andrew J Broadbent; Celia P Santos; Myeisha Paskel; Yumiko Matsuoka; Janine Lu; Zhongying Chen; Hong Jin; Kanta Subbarao
Journal:  Vaccine       Date:  2014-11-06       Impact factor: 3.641

6.  New reassortant and enzootic European swine influenza viruses transmit efficiently through direct contact in the ferret model.

Authors:  Kristina Fobian; Thomas P Fabrizio; Sun-Woo Yoon; Mette Sif Hansen; Richard J Webby; Lars E Larsen
Journal:  J Gen Virol       Date:  2015-02-20       Impact factor: 3.891

7.  Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.

Authors:  Daniel Dlugolenski; Les Jones; Elizabeth Howerth; David Wentworth; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 8.  Continuing challenges in influenza.

Authors:  Robert G Webster; Elena A Govorkova
Journal:  Ann N Y Acad Sci       Date:  2014-05-30       Impact factor: 5.691

9.  A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.

Authors:  Sergio M Quiñones-Parra; E Bridie Clemens; Zhongfang Wang; Hayley A Croom; Lukasz Kedzierski; Jodie McVernon; Dhanasekaran Vijaykrishna; Katherine Kedzierska
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  Genetic and molecular characterization of a novel reassortant H2N8 subtype avian influenza virus isolated from a domestic duck in Zhejiang Province in China.

Authors:  Haibo Wu; Xiuming Peng; Xiaorong Peng; Linfang Cheng; Nanping Wu
Journal:  Virus Genes       Date:  2016-07-05       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.